Cargando…
Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress
The best treatment for end-stage renal disease is renal transplantation. However, it is often difficult to maintain a renal allograft healthy for a long time following transplantation. Interstitial fibrosis and tubular atrophy (IF/TA) are significant histopathologic characteristics of a compromised...
Autores principales: | Wang, Yishu, Pang, Lei, Zhang, Yanghe, Lin, Jiahui, Zhou, Honglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397988/ https://www.ncbi.nlm.nih.gov/pubmed/30911353 http://dx.doi.org/10.1155/2019/8936856 |
Ejemplares similares
-
Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013) -
Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
por: Wang, Hong-Wei, et al.
Publicado: (2017) -
Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013) -
Targeted changes in blood lipids improves fibrosis in renal allografts
por: Zhang, Yang-He, et al.
Publicado: (2023) -
Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
por: SHAN, GUANG, et al.
Publicado: (2016)